Unresectable Locally Advanced Pancreatic Cancer: Treatment With Neoadjuvant Leucovorin, Fluorouracil, Irinotecan, and Oxaliplatin and Assessment of Surgical Resectability

被引：9
|
作者：
Mondo, Esther Liu [1 ]
Noel, Marcus S. [2 ]
Katz, Alan W. [2 ]
Schoeniger, Luke O. [2 ]
Hezel, Aram F. [2 ]
机构：
[1] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14627 USA
[2] Univ Rochester, Med Ctr, Sch Med & Dent, James P Wilmot Canc Ctr, Rochester, NY 14642 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 03期
关键词：
CHEMOTHERAPY; GEMCITABINE;
D O I：
10.1200/JCO.2012.44.0339
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E37 / E39
页数：3
相关论文
共 50 条
  • [1] A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer
    Cecchini, Michael
    Miccio, Joseph A.
    Pahade, Jay
    Lacy, Jill
    Salem, Ronald R.
    Johnson, Skyler B.
    Blakaj, Adriana
    Stein, Stacey
    Kortmansky, Jeremy S.
    Johung, Kimberly L.
    PANCREAS, 2020, 49 (07) : 904 - 911
  • [2] Oxaliplatin, 5-Fluorouracil, and Leucovorin as Second-Line Treatment for Advanced Pancreatic Cancer
    Novarino, Anna
    Satolli, Maria Antonietta
    Chiappino, Isabella
    Giacobino, Alice
    Bellone, Graziella
    Rahimi, Farnaz
    Milanesi, Enrica
    Bertetto, Oscar
    Ciuffreda, Libero
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 44 - 48
  • [3] NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer
    Sahora, Klaus
    Kuehrer, Irene
    Eisenhut, Axel
    Akan, Belgin
    Koellblinger, Claus
    Goetzinger, Peter
    Teleky, Bela
    Jakesz, Raimund
    Peck-Radosavljevic, Markus
    Ba'ssalamah, Ahmed
    Zielinski, Christoph
    Gnant, Michael
    SURGERY, 2011, 149 (03) : 311 - 320
  • [4] Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer
    Zhang, Yonglei
    Zhang, Bin
    Yang, Jinpo
    Zhang, Jindai
    Zhang, Wei
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2279 - 2286
  • [5] Neoadjuvant modified FOLFIRINOX and chemoradiation therapy for locally advanced pancreatic cancer improves resectability
    Nanda, Ronica H.
    El-Rayes, Bassel
    Maithel, Shishir K.
    Landry, Jerome
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (08) : 1028 - 1034
  • [6] Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX
    Michelakos, Theodoros
    Pergolini, Ilaria
    Fernandez-del Castillo, Carlos
    Honselmann, Kim C.
    Cai, Lei
    Deshpande, Vikram
    Wo, Jennifer Y.
    Ryan, David P.
    Allen, Jill N.
    Blaszkowsky, Lawrence S.
    Clark, Jeffrey W.
    Murphy, Janet E.
    Nipp, Ryan D.
    Parikh, Aparna
    Qadan, Motaz
    Warshaw, Andrew L.
    Hong, Theodore S.
    Lillemoe, Keith D.
    Ferrone, Cristina R.
    ANNALS OF SURGERY, 2019, 269 (04) : 733 - 740
  • [7] Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer
    Strobel, Oliver
    Berens, Viktoria
    Hinz, Ulf
    Hartwig, Werner
    Hackert, Thilo
    Bergmann, Frank
    Debus, Juergen
    Jaeger, Dirk
    Buechler, Markus W.
    Werner, Jens
    SURGERY, 2012, 152 (03) : S33 - S42
  • [8] Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer
    Cao, Weiguo
    Yang, Weiping
    Lou, Guying
    Jiang, Jinsong
    Geng, Mei
    Xi, Wenqi
    Li, Hao
    Ma, Tao
    Jin, Yening
    ANTI-CANCER DRUGS, 2009, 20 (04) : 287 - 293
  • [9] Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
    Ferrone, Cristina R.
    Marchegiani, Giovanni
    Hong, Theodore S.
    Ryan, David P.
    Deshpande, Vikram
    McDonnell, Erin I.
    Sabbatino, Francesco
    Santos, Daniela Dias
    Allen, Jill N.
    Blaszkowsky, Lawrence S.
    Clark, Jeffrey W.
    Faris, Jason E.
    Goyal, Lipika
    Kwak, Eunice L.
    Murphy, Janet E.
    Ting, David T.
    Wo, Jennifer Y.
    Zhu, Andrew X.
    Warshaw, Andrew L.
    Lillemoe, Keith D.
    Fernandez-del Castillo, Carlos
    ANNALS OF SURGERY, 2015, 261 (01) : 12 - 17
  • [10] Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer
    Scheufele, Florian
    Hartmann, Daniel
    Friess, Helmut
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
12345